{"ticker": {"uuid": "f2e15eba-2543-42d8-90a5-a50058dbac76", "symbol": "BOT", "name": "Botanix Pharmaceuticals Limited", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Botanix Pharmaceuticals (ASX:BOT) Leads a New ASX Penny Stocks Focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOTjltUFktamRvX0FXdV9BZWczTEU2VnkzRTBlc3BTRmNjQnE5MlZyWHNRUVdlQ0U5Z3VpUG5YaWRnUzNtYktYSjNmZWFaeVpWWnA2X3lxLXR4UUxCNm9jWndZMHdDa1BxUzZWaElIVzlNR0Q4eHBoWUJ2VW1oR3ZMQllOMW9TRVVCdnk4czFEakVDdVdGa3k1ZmxiQzQ3bnBzSkV3UzViakFuUQ?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Botanix Pharmaceuticals (ASX:BOT): Why Do Biotech Milestones Matter?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPSGE3RDlGODJfMW1CUTAycHU2X3JJcjhRSGxqRWItaUxFY1NaUDYwVm5oMzMxZFpOLWVKSVdXTE1acHhYM3hKVHUxd3V6NE5WN1o2blNCeDBQN3VoZkJaQVVuUmM2ZGoxcWJMcGhqR21ROXYyZTlhQ1V2V0dpZXBQTWFOOUJQZnJkNkpISkdtZ2dZX2dIdlptTFp3NTY1b3RmZzB0SjNFNA?oc=5", "source_name": "Kalkine Media", "published_at": "2026-06-30T08:37:00+00:00", "published_display": "30 Jun 2026 08:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Botanix Pharmaceuticals (ASX: BOT) Stays Hot as Biotech Traders Debate the Next Catalyst", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQbWZYUWxpc292RlpKMnlqMGFFZ3JDbWt5ekU3STRoWXFHd2l4TE90bEVBbmNJZFRoU3Vva2U5bXYwajlHQ1Z2ajRBUHpHQ3lhUEw3aUtVQzUxYlZQMk01ZkQyVDI3VUYzVklOMUxSR1EzVHpZNEdjaHp6TnlmN2dYQ1BobTQ3cWUtSHJTMlo0RUpURWxTRUFkTWVhNk1ka0w2bkxWQVEwMzl6c1JmNW9uTjBoLWt3eW5sNmcwdGxvVVNPVjhh?oc=5", "source_name": "Kalkine", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Botanix Pharmaceuticals (ASX:BOT): Healthcare Stock Keeps Traders Watching Beyond the Chart", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNX09ER2M0bURKRTJJZndFTHRQS3N4UHFrRkd4NnM4ZVZkMkFLU3lOWGxTSW10eDNlYlQtMUNJNW4xM21hb0IybjM5UjFpVENaRFpoNEdncmIwQVFzVTAzUDltTGt5ZDFGd0FvUUQ3dmJuYWxDSFBWb1ljWEFVRVFodTV2R25YQ0N3eTRVMk52SlhDQ0VHUEtnVk1LRHpKcFZTVmQ4Uk1XbTBOWjVYcVdyUHBxM2ZMWlJ5UzdtMVoxM2JLTkFE?oc=5", "source_name": "Kalkine", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evaluating Botanix Pharmaceuticals (ASX:BOT) After A$45 Million Equity Raise For Sofdra Rollout", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQRk00Vm01V3hVWWJ3MnVSMV9tdWpJb0xOaHA1OWVwcUtndFlrakpzZ0JpNWtIX1FIdE5QSDhrZFBVcmwxU25heldqSm50OEhYNTNTR2hBZmVFY2JmajZUX2Y3amZ0S3RIVkdVenh3N2JLa3gtdHFlOU8wOU9tLWJDTmlPenAtSW9EU1RDc2REdmFBdw?oc=5", "source_name": "Market source", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Botanix Pharmaceuticals (ASX:BOT) Valuation After Its A$45m Follow On Equity Offerings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Botanix raises $45m to fuel Sofdra growth and secure global supply chain", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPZzZBMGg0b2RSVnQ5SjRBVEh2UHVwRHNjTUNmZTJuNEV2aVU2c0F2dkcydGd1WTljU1VYQ0pOeDg3UmNhbGdSUHdjVXBmVkxJdmZhb1VpQzdVN3V2WDhjaHd0T2VOdERMU1JRNEJIUXE4Yk5ONTJ0VGViUjNORzlYcW9zUVdoUnB4QjA4Uy1iRll0SUwtd0dpUWYwcE1pMHFfZVpoZTdUTElKOEJ1dmZZUzItMTI?oc=5", "source_name": "BiotechDispatch", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think Botanix Pharmaceuticals (ASX:BOT) Needs To Drive Business Growth Carefully", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQb0E5cERfa2Y3TlhnZXNXY29nVEV2ck55Y0loN0dXbDEwcENkRTRsQnpSNDYzcEdXZzBCNXZJcS1halhKV09CUzMybGtTVVNqRDdEX202MXVVS2dBY3BJWG8wWFUxdElYd05LVGZRM1hBUVBLZnEwYVVMS3ZlU3FrY2FGQVZ4NFZ1bENJ?oc=5", "source_name": "Market source", "published_at": "2025-11-20T08:00:00+00:00", "published_display": "20 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insights: Botanix Pharmaceuticals Ltd (ASX:BOT)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE9HbW1VTTI0aERZdTB0ZW5LZURWR2tqbHdSUVJ6cFhTdmk4WUVIaHREQ3lVMURJTzJmV1ZBTzZfbFlfNWtCS19hRWR3d2pVajIy?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-10-31T02:06:11+00:00", "published_display": "31 Oct 2025 02:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will Botanix Pharmaceuticals\u2019 (ASX:BOT) Investor Outreach Reinforce Management Credibility or Raise Fresh Questions?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-10-29T07:00:00+00:00", "published_display": "29 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Botanix Pharmaceuticals (ASX:BOT): Evaluating Valuation as Management Updates and Sofdra Launch Draw Investor Focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxOYUxIM3liM0VqeEYwaUJ6RktDQkc1OUVjUDAtMnRFVXQxMGRUUzluVW5Xc0JRSkhqZzRXQnRsR3NNelZaRHBGQk1ucFUtNFI0elozR2hlR3RjWER1RzVRbHVYVm1WZE1oOWY4YU44VHBLSExMVC1aZDlHSEZ2OVc3SzZ6TUt4RW1YRDBuWm9fM3Nzdw?oc=5", "source_name": "Market source", "published_at": "2025-10-23T07:00:00+00:00", "published_display": "23 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "While Botanix Pharmaceuticals (ASX:BOT) shareholders have made 123% in 3 years, increasing losses might now be front of mind as stock sheds 12% this week", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-10-10T07:00:00+00:00", "published_display": "10 Oct 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Expect Breakeven For Botanix Pharmaceuticals Limited (ASX:BOT) Before Long", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQWG5ybDdZZGxVVGxCYnc5ZFBjRFRNM2ZCcktQZ2xmRGt3OVRxaE1JNlJINFZpbXdwYjlQcmhMS1ZNSkpsY2k5d3d6am8zcGtXZlFKeUtpQVktekVTOVZEQnY1d2RZeHVLaExiQkNaS2pXY3pzSzkzZDNITzV6TjhMckNVTzhEMmY4Z0tYazA4dnJoRHo3dF9heWVyTQ?oc=5", "source_name": "Market source", "published_at": "2025-10-07T07:00:00+00:00", "published_display": "07 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilbert + Tobin advises Botanix Pharmaceuticals Limited on cross-border debt facility with Kreos Capital", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNb0ltcWc5b3NYWmVscjEtcVZENTc5c0hjb1dic0tSS0RFMk1mQi1SM1RaQWR4elhUbFZ4Z0RmTXBBaHFQYV95WXF5YmhoYkJUR0tna1NfN2lFZkhmRjFZYk55Sk5DY2RQOUozQzUxZnVUVkNKbXRQaGQtdThrZUZoUnpBT1JhQ0ZiUkttb0VuZHBKenlhQnZOMHpqQVRfdHdWWjExNFk2SENJU2EzT0VPeDA0cHpPOENXUVpFcnpuN2syZWZaQ1hWNUNCSmM?oc=5", "source_name": "Gilbert + Tobin", "published_at": "2025-06-25T07:00:00+00:00", "published_display": "25 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Botanix Pharmaceuticals (ASX:BOT) Leads a New ASX Penny Stocks Focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOTjltUFktamRvX0FXdV9BZWczTEU2VnkzRTBlc3BTRmNjQnE5MlZyWHNRUVdlQ0U5Z3VpUG5YaWRnUzNtYktYSjNmZWFaeVpWWnA2X3lxLXR4UUxCNm9jWndZMHdDa1BxUzZWaElIVzlNR0Q4eHBoWUJ2VW1oR3ZMQllOMW9TRVVCdnk4czFEakVDdVdGa3k1ZmxiQzQ3bnBzSkV3UzViakFuUQ?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Botanix Pharmaceuticals (ASX:BOT): Why Do Biotech Milestones Matter?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPSGE3RDlGODJfMW1CUTAycHU2X3JJcjhRSGxqRWItaUxFY1NaUDYwVm5oMzMxZFpOLWVKSVdXTE1acHhYM3hKVHUxd3V6NE5WN1o2blNCeDBQN3VoZkJaQVVuUmM2ZGoxcWJMcGhqR21ROXYyZTlhQ1V2V0dpZXBQTWFOOUJQZnJkNkpISkdtZ2dZX2dIdlptTFp3NTY1b3RmZzB0SjNFNA?oc=5", "source_name": "Kalkine Media", "published_at": "2026-06-30T08:37:00+00:00", "published_display": "30 Jun 2026 08:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Botanix Pharmaceuticals (ASX: BOT) Stays Hot as Biotech Traders Debate the Next Catalyst", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQbWZYUWxpc292RlpKMnlqMGFFZ3JDbWt5ekU3STRoWXFHd2l4TE90bEVBbmNJZFRoU3Vva2U5bXYwajlHQ1Z2ajRBUHpHQ3lhUEw3aUtVQzUxYlZQMk01ZkQyVDI3VUYzVklOMUxSR1EzVHpZNEdjaHp6TnlmN2dYQ1BobTQ3cWUtSHJTMlo0RUpURWxTRUFkTWVhNk1ka0w2bkxWQVEwMzl6c1JmNW9uTjBoLWt3eW5sNmcwdGxvVVNPVjhh?oc=5", "source_name": "Kalkine", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Botanix Pharmaceuticals (ASX:BOT): Healthcare Stock Keeps Traders Watching Beyond the Chart", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNX09ER2M0bURKRTJJZndFTHRQS3N4UHFrRkd4NnM4ZVZkMkFLU3lOWGxTSW10eDNlYlQtMUNJNW4xM21hb0IybjM5UjFpVENaRFpoNEdncmIwQVFzVTAzUDltTGt5ZDFGd0FvUUQ3dmJuYWxDSFBWb1ljWEFVRVFodTV2R25YQ0N3eTRVMk52SlhDQ0VHUEtnVk1LRHpKcFZTVmQ4Uk1XbTBOWjVYcVdyUHBxM2ZMWlJ5UzdtMVoxM2JLTkFE?oc=5", "source_name": "Kalkine", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evaluating Botanix Pharmaceuticals (ASX:BOT) After A$45 Million Equity Raise For Sofdra Rollout", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQRk00Vm01V3hVWWJ3MnVSMV9tdWpJb0xOaHA1OWVwcUtndFlrakpzZ0JpNWtIX1FIdE5QSDhrZFBVcmwxU25heldqSm50OEhYNTNTR2hBZmVFY2JmajZUX2Y3amZ0S3RIVkdVenh3N2JLa3gtdHFlOU8wOU9tLWJDTmlPenAtSW9EU1RDc2REdmFBdw?oc=5", "source_name": "Market source", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Botanix Pharmaceuticals (ASX:BOT) Valuation After Its A$45m Follow On Equity Offerings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Botanix raises $45m to fuel Sofdra growth and secure global supply chain", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPZzZBMGg0b2RSVnQ5SjRBVEh2UHVwRHNjTUNmZTJuNEV2aVU2c0F2dkcydGd1WTljU1VYQ0pOeDg3UmNhbGdSUHdjVXBmVkxJdmZhb1VpQzdVN3V2WDhjaHd0T2VOdERMU1JRNEJIUXE4Yk5ONTJ0VGViUjNORzlYcW9zUVdoUnB4QjA4Uy1iRll0SUwtd0dpUWYwcE1pMHFfZVpoZTdUTElKOEJ1dmZZUzItMTI?oc=5", "source_name": "BiotechDispatch", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think Botanix Pharmaceuticals (ASX:BOT) Needs To Drive Business Growth Carefully", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQb0E5cERfa2Y3TlhnZXNXY29nVEV2ck55Y0loN0dXbDEwcENkRTRsQnpSNDYzcEdXZzBCNXZJcS1halhKV09CUzMybGtTVVNqRDdEX202MXVVS2dBY3BJWG8wWFUxdElYd05LVGZRM1hBUVBLZnEwYVVMS3ZlU3FrY2FGQVZ4NFZ1bENJ?oc=5", "source_name": "Market source", "published_at": "2025-11-20T08:00:00+00:00", "published_display": "20 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insights: Botanix Pharmaceuticals Ltd (ASX:BOT)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE9HbW1VTTI0aERZdTB0ZW5LZURWR2tqbHdSUVJ6cFhTdmk4WUVIaHREQ3lVMURJTzJmV1ZBTzZfbFlfNWtCS19hRWR3d2pVajIy?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-10-31T02:06:11+00:00", "published_display": "31 Oct 2025 02:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Will Botanix Pharmaceuticals\u2019 (ASX:BOT) Investor Outreach Reinforce Management Credibility or Raise Fresh Questions?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-10-29T07:00:00+00:00", "published_display": "29 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Botanix Pharmaceuticals (ASX:BOT): Evaluating Valuation as Management Updates and Sofdra Launch Draw Investor Focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxOYUxIM3liM0VqeEYwaUJ6RktDQkc1OUVjUDAtMnRFVXQxMGRUUzluVW5Xc0JRSkhqZzRXQnRsR3NNelZaRHBGQk1ucFUtNFI0elozR2hlR3RjWER1RzVRbHVYVm1WZE1oOWY4YU44VHBLSExMVC1aZDlHSEZ2OVc3SzZ6TUt4RW1YRDBuWm9fM3Nzdw?oc=5", "source_name": "Market source", "published_at": "2025-10-23T07:00:00+00:00", "published_display": "23 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "While Botanix Pharmaceuticals (ASX:BOT) shareholders have made 123% in 3 years, increasing losses might now be front of mind as stock sheds 12% this week", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-10-10T07:00:00+00:00", "published_display": "10 Oct 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Expect Breakeven For Botanix Pharmaceuticals Limited (ASX:BOT) Before Long", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQWG5ybDdZZGxVVGxCYnc5ZFBjRFRNM2ZCcktQZ2xmRGt3OVRxaE1JNlJINFZpbXdwYjlQcmhMS1ZNSkpsY2k5d3d6am8zcGtXZlFKeUtpQVktekVTOVZEQnY1d2RZeHVLaExiQkNaS2pXY3pzSzkzZDNITzV6TjhMckNVTzhEMmY4Z0tYazA4dnJoRHo3dF9heWVyTQ?oc=5", "source_name": "Market source", "published_at": "2025-10-07T07:00:00+00:00", "published_display": "07 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilbert + Tobin advises Botanix Pharmaceuticals Limited on cross-border debt facility with Kreos Capital", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNb0ltcWc5b3NYWmVscjEtcVZENTc5c0hjb1dic0tSS0RFMk1mQi1SM1RaQWR4elhUbFZ4Z0RmTXBBaHFQYV95WXF5YmhoYkJUR0tna1NfN2lFZkhmRjFZYk55Sk5DY2RQOUozQzUxZnVUVkNKbXRQaGQtdThrZUZoUnpBT1JhQ0ZiUkttb0VuZHBKenlhQnZOMHpqQVRfdHdWWjExNFk2SENJU2EzT0VPeDA0cHpPOENXUVpFcnpuN2syZWZaQ1hWNUNCSmM?oc=5", "source_name": "Gilbert + Tobin", "published_at": "2025-06-25T07:00:00+00:00", "published_display": "25 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 90, "total_relevant": 14, "sentiment_summary": {"positive": 4, "negative": 1, "neutral": 9, "score": 55, "total": 14, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 90, "events": [{"event": "general", "label": "Market update", "weight": 6.6, "count": 12}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 0.02, "latest_week": "2026-07-10", "one_week_move": 14.3, "four_week_move": 4.3, "twelve_week_move": -35.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.286354, "market_dynamics_buy_signal": false, "relative_strength": -74.609018, "fair_value_gap": -89.4, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 29.4501, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+14.3% over one week, +4.3% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 68, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 4}, {"label": "simplywall.st", "count": 3}, {"label": "Kalkine Media", "count": 2}, {"label": "Kalkine", "count": 2}, {"label": "BiotechDispatch", "count": 1}, {"label": "smallcaps.com.au", "count": 1}, {"label": "Gilbert + Tobin", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 14}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 12}, {"label": "Macro sensitivity", "count": 1}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "90/100 classification confidence."}, {"label": "Company focus", "value": "14", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+14.3% over one week, +4.3% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Botanix Pharmaceuticals (ASX:BOT) Leads a New ASX Penny Stocks Focus"}], "updated_at": "2026-07-17T06:04:59.783471+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}